Research advances on the value of preoperative systemic inflammatory response index in predicting the prognosis of patients with resectable pancreatic cancer
10.3760/cma.j.issn.0529?5815.2019.11.013
- VernacularTitle:术前全身炎症反应指标预测可切除性胰腺癌患者预后价值的研究进展
- Author:
Chengpeng JIA
1
;
Hua CHEN
;
Bei SUN
Author Information
1. 哈尔滨医科大学附属第一医院胰胆外科150001
- Keywords:
Pancreatic neoplasms;
Systemic inflammatory response;
Prognosis;
Prediction
- From:
Chinese Journal of Surgery
2019;57(11):862-865
- CountryChina
- Language:Chinese
-
Abstract:
Pancreatic cancer is a highly malignant gastrointestinal tumor with high invasiveness, easy metastasis, and poor chemoresistance. Surgery is still the preferred treatment for resectable pancreatic cancer. At present,inflammatory scoring systems based on serological indicators in patients with resectable pancreatic cancer can be divided into two types:the inflammatory scoring system based on c?reactive protein albumin and the inflammatory scoring system based on peripheral blood cell count. However, the specific mechanism between these inflammatory markers and the prognostic value of resectable pancreatic cancer remains unclear. This article reviews the correlation between systemic inflammatory response indexes and prognosis of patients with resectable pancreatic cancer,so as to provide help for the comprehensive treatment of pancreatic cancer.
